Christopher Kenney

Christopher Kenney

Chief Medical OfficeratXenon Pharmaceuticals· In proxies 2021–2025

Pay in FY2022+69% from the year before · Xenon Pharmaceuticals stock +26.2% the same year

Christopher Kenney was paid $3.3M in FY2022 (Dec), up 69%. Xenon Pharmaceuticals stock rose 26.2% that year.

Pay$100 in the stock at the end of FY20 → $256
Pay is from the Summary Compensation Table of each Xenon Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Xenon PharmaceuticalsPublic company · 5 yr
    • Chief Medical Officer2021 – Present · 5 yrStock in role +138%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?